Search Results

There are 7908 results for: content related to: Safety and efficacy of low-dose fondaparinux (1.5 mg) for the prevention of venous thromboembolism in acutely ill medical patients with renal impairment: the FONDAIR study

  1. You have free access to this content
    Abstracts

    Journal of Thrombosis and Haemostasis

    Volume 3, Issue s1, August 2005, Pages: H01–SYM90,

    Version of Record online : 6 SEP 2013, DOI: 10.1111/j.1538-7836.2005.03000.x

  2. Pentasaccharide Derivatives

    Therapeutic Advances in Thrombosis, Second Edition

    Antonio Gutierrez, Pierluigi Tricoci, John H. P. Alexander, Pages: 128–149, 2012

    Published Online : 3 OCT 2012, DOI: 10.1002/9781118410875.ch9

  3. You have free access to this content
    Abstracts

    Journal of Thrombosis and Haemostasis

    Volume 3, Issue s1, August 2005, Pages: P0001–P2386,

    Version of Record online : 9 SEP 2013, DOI: 10.1111/j.1538-7836.2005.0300c.x

  4. Fondaparinux-associated heparin-induced thrombocytopenia

    European Journal of Haematology

    Volume 91, Issue 5, November 2013, Pages: 437–441, Vijaya R. Bhatt, Madan R. Aryal, Rajesh Shrestha and James O. Armitage

    Version of Record online : 19 AUG 2013, DOI: 10.1111/ejh.12179

  5. You have free access to this content
    Fondaparinux, a Synthetic Pentasaccharide: The First in a New Class of Antithrombotic Agents — The Selective Factor Xa Inhibitors

    Cardiovascular Drug Reviews

    Volume 20, Issue 1, March 2002, Pages: 37–52, Kenneth A. Bauer, David W. Hawkins, Paul C. Peters, Maurice Petitou, Jean-Marc Herbert, Constant A. A. van Boeckel and Dirk G. Meuleman

    Version of Record online : 7 JUN 2006, DOI: 10.1111/j.1527-3466.2002.tb00081.x

  6. You have free access to this content
    Posters

    Journal of Thrombosis and Haemostasis

    Volume 7, Issue s2, July 2009, Pages: 317–1168,

    Version of Record online : 15 JUN 2009, DOI: 10.1111/j.1538-7836.2009.03473_2.x

  7. You have free access to this content
    Abstract

    Journal of Thrombosis and Haemostasis

    Volume 5, Issue S2, July 2007, Pages: P-M-501–P-M-701,

    Version of Record online : 13 FEB 2014, DOI: 10.1111/j.1538-7836.2007.tb00020.x

  8. You have free access to this content
    Fondaparinux combined with intermittent pneumatic compression vs. intermittent pneumatic compression alone for prevention of venous thromboembolism after abdominal surgery: a randomized, double-blind comparison

    Journal of Thrombosis and Haemostasis

    Volume 5, Issue 9, September 2007, Pages: 1854–1861, A. G. G. TURPIE, K. A. BAUER, J. A. CAPRINI, P. C. COMP, M. GENT, J. E. MUNTZ and ON BEHALF OF THE APOLLO INVESTIGATORS

    Version of Record online : 15 JUN 2007, DOI: 10.1111/j.1538-7836.2007.02657.x

  9. Anticoagulation With Fondaparinux for Hemodiafiltration in Patients With Heparin-Induced Thrombocytopenia: Dose-Finding Study and Safety Evaluation

    Artificial Organs

    Volume 37, Issue 5, May 2013, Pages: 482–487, Elien Mahieu, Kathleen Claes, Marc Jacquemin, Pieter Evenepoel, Karel Op De Beek, Anne-Marie Bogaert, Dirk Kuypers, Peter Verhamme and Björn Meijers

    Version of Record online : 5 MAR 2013, DOI: 10.1111/aor.12002

  10. You have free access to this content
    Abstract

    Journal of Thrombosis and Haemostasis

    Volume 1, Issue S1, July 2003, Pages: P2016–P2083a,

    Version of Record online : 7 MAR 2014, DOI: 10.1111/j.1538-7836.2003.tb00129.x

  11. Emerging Options for Thromboprophylaxis After Orthopedic Surgery: A Review of Clinical Data

    Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy

    Volume 24, Issue 7P2, July 2004, Pages: 66S–72S, Bob L. Lobo

    Version of Record online : 16 JAN 2012, DOI: 10.1592/phco.24.10.66S.36117

  12. You have free access to this content
    Abstract

    Journal of Thrombosis and Haemostasis

    Volume 5, Issue S2, July 2007, Pages: P-T-401–P-T-700,

    Version of Record online : 13 FEB 2014, DOI: 10.1111/j.1538-7836.2007.tb00029.x

  13. Fondaparinux vs. enoxaparin in patients with non-ST elevation acute coronary syndromes (NSTE-ACS) treated with percutaneous coronary intervention and tirofiban: an exploratory study in China

    Journal of Clinical Pharmacy and Therapeutics

    Volume 40, Issue 5, October 2015, Pages: 584–589, X. M. Zhao, C. Y. Gao, Y. J. Chu, L. Yang, X. Z. Yang, W. K. Xu, W. Q. He, P. R. Zhang, X. Y. Liu and L. X. Tian

    Version of Record online : 6 AUG 2015, DOI: 10.1111/jcpt.12315

  14. Fondaparinux in the Cardiac Catheterization Laboratory

    Pharmacology in the Catheterization Laboratory

    Michael D. White, Richard C. Becker, Pages: 23–30, 2009

    Published Online : 30 OCT 2009, DOI: 10.1002/9781444306347.ch4

  15. You have free access to this content
    Efficacy and safety of venous thromboembolism prophylaxis with fondaparinux or low molecular weight heparin in a large cohort of consecutive patients undergoing major orthopaedic surgery – findings from the ORTHO-TEP registry

    British Journal of Clinical Pharmacology

    Volume 74, Issue 6, December 2012, Pages: 947–958, Lars Donath, Jörg Lützner, Sebastian Werth, Eberhard Kuhlisch, Albrecht Hartmann, Klaus-Peter Günther, Norbert Weiss and Jan Beyer-Westendorf

    Version of Record online : 13 NOV 2012, DOI: 10.1111/j.1365-2125.2012.04302.x

  16. You have free access to this content
    Efficacy and safety of rivaroxaban or fondaparinux thromboprophylaxis in major orthopedic surgery: findings from the ORTHO-TEP registry

    Journal of Thrombosis and Haemostasis

    Volume 10, Issue 10, October 2012, Pages: 2045–2052, J. BEYER-WESTENDORF, J. LÜTZNER, L. DONATH, O. C. RADKE, E. KUHLISCH, A. HARTMANN, N. WEISS and S. WERTH

    Version of Record online : 1 OCT 2012, DOI: 10.1111/j.1538-7836.2012.04877.x

  17. Fondaparinux as a Treatment Option for Heparin-Induced Thrombocytopenia

    Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy

    Volume 27, Issue 6, June 2007, Pages: 921–926, Dr. Stella Papadopoulos, Dr. Jeremy D. Flynn and Dr. Daniel A. Lewis

    Version of Record online : 6 JAN 2012, DOI: 10.1592/phco.27.6.921

  18. You have free access to this content
    Heparin-induced thrombocytopenia – therapeutic concentrations of danaparoid, unlike fondaparinux and direct thrombin inhibitors, inhibit formation of platelet factor 4–heparin complexes

    Journal of Thrombosis and Haemostasis

    Volume 6, Issue 12, December 2008, Pages: 2160–2167, K. KRAUEL, B. FÜRLL, T. E. WARKENTIN, W. WEITSCHIES, T. KOHLMANN, J. I. SHEPPARD and A. GREINACHER

    Version of Record online : 3 OCT 2008, DOI: 10.1111/j.1538-7836.2008.03171.x

  19. You have free access to this content
    Fondaparinux treatment of acute heparin-induced thrombocytopenia confirmed by the serotonin-release assay: a 30-month, 16-patient case series

    Journal of Thrombosis and Haemostasis

    Volume 9, Issue 12, December 2011, Pages: 2389–2396, T. E. WARKENTIN, M. PAI, J. I. SHEPPARD, S. SCHULMAN, A. C. SPYROPOULOS and J. W. EIKELBOOM

    Version of Record online : 1 DEC 2011, DOI: 10.1111/j.1538-7836.2011.04487.x

  20. Bivalirudin versus Unfractionated Heparin during Percutaneous Coronary Intervention in Patients with Non-ST-Segment Elevation Acute Coronary Syndrome Initially Treated with Fondaparinux: Results from an International, Multicenter, Randomized Pilot Study (SWITCH III)

    Journal of Interventional Cardiology

    Volume 26, Issue 2, April 2013, Pages: 107–113, RON WAKSMAN, OLIVIER BERTRAND, MITCHELL DRIESMAN, LUIS GRUBERG, JOSEPH ROSSI, SHAMIR MEHTA, STACY SWYMELAR, DANNY DVIR, ZHENYI XUE and REBECCA TORGUSON

    Version of Record online : 13 DEC 2012, DOI: 10.1111/joic.12005